UBE2C Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant UBE2C.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC, IF, E |
---|---|
Primary Accession | O00762 |
Other Accession | NM_007019 |
Reactivity | Human |
Host | mouse |
Clonality | Monoclonal |
Isotype | IgG2a Kappa |
Clone Names | 9D3 |
Calculated MW | 19652 Da |
Gene ID | 11065 |
---|---|
Other Names | Ubiquitin-conjugating enzyme E2 C, UbcH10, Ubiquitin carrier protein C, Ubiquitin-protein ligase C, UBE2C, UBCH10 |
Target/Specificity | UBE2C (NP_008950, 70 a.a. ~ 179 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | UBE2C Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
1.Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions.Chou CP, Huang NC, Jhuang SJ, Pan HB, Peng NJ, Cheng JT, Chen CF, Chen JJ, Chang THPLoS One. 2014 Apr 3;9(4):e93934. doi: 10.1371/journal.pone.0093934. eCollection 2014.2.Oligonucleotide Microarray Identifies Genes Differentially Expressed during Tumorigenesis of DMBA-Induced Pancreatic Cancer in Rats.Guo JC, Li J, Yang YC, Zhou L, Zhang TP, Zhao YPPLoS One. 2013 Dec 23;8(12):e82910. doi: 10.1371/journal.pone.0082910.3.UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Morikawa T, Kawai T, Abe H, Kume H, Homma Y, Fukayama MInt J Clin Exp Pathol. 2013 Jun 15;6(7):1367-74. Print 2013.4.Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle Invasive Bladder Cancer.Fristrup N, Birkenkamp-Demtroder K, Reinert T, Sanchez-Carbayo M, Segersten U, Malmstrom PU, Palou J, Alvarez-Mugica M, Pan CC, Ulhoi BP, Borre M, Orntoft TF, Dyrskjot L.Am J Pathol. 2012 Nov 28. pii: S0002-9440(12)00811-5. doi: 10.1016/j.ajpath.2012.10.017.5.A study of UbcH10 expression and its association with recurrence of meningiomas.Jiang L, Wang T, Bao Y, Qian J, Wu XJ, Hu GH, Lu YC.J Surg Oncol. 2012 Sep 1;106(3):327-31. doi: 10.1002/jso.22141. Epub 2011 Nov 17.6.Association of clinicopathological features with UbcH10 expression in colorectal cancer.Chen S, Chen Y, Hu C, Jing H, Cao Y, Liu X.J Cancer Res Clin Oncol. 2009 Sep 25. [Epub ahead of print]7.Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors.Jiang L, Huang CG, Lu YC, Luo C, Hu GH, Liu HM, Chen JX, Han HX.Brain Res. 2008 Mar 27;1201:161-6. Epub 2008 Jan 26.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.